PMC8721406_01
Pre-treatment umbilical keloid.
10.1177_20595131211049040-fig1.jpg
PMC8721406_01_10.1177_20595131211049040-fig1.jpg
fig1-20595131211049040
A 31-year-old woman of Fitzpatrick skin type IV presented with an over two-year history of a large 2 cm thick pedunculated keloid located in the umbilical region following a piercing (Figure 1).
Keloid treatment with intralesional cryotherapy.
10.1177_20595131211049040-fig2.jpg
PMC8721406_01_10.1177_20595131211049040-fig2.jpg
fig2-20595131211049040
A disposable single-use cryoprobe was inserted through the keloid (Figure 2).
Keloid 1 day post-intralesional cryotherapy.
10.1177_20595131211049040-fig3.jpg
PMC8721406_01_10.1177_20595131211049040-fig3.jpg
fig3-20595131211049040
The patient was asked to send photos documenting the keloid healing process during the first month post-procedure (Figures 3 and 4).
Keloid 19 days post-intralesional cryotherapy.
10.1177_20595131211049040-fig4.jpg
PMC8721406_01_10.1177_20595131211049040-fig4.jpg
fig4-20595131211049040
The patient was asked to send photos documenting the keloid healing process during the first month post-procedure (Figures 3 and 4).
Keloid 28 days post-intralesional cryotherapy.
10.1177_20595131211049040-fig5.jpg
PMC8721406_01_10.1177_20595131211049040-fig5.jpg
fig5-20595131211049040
The patient was seen for a follow-up 28 days post-procedure (Figure 5).
Keloid 63 days post-intralesional cryotherapy.
10.1177_20595131211049040-fig6.jpg
PMC8721406_01_10.1177_20595131211049040-fig6.jpg
fig6-20595131211049040
After 63 days post-procedure, the patient started using a twice daily topical treatment consisting of niacinamide, tranexamic acid, 1,4-diaminobutane dihydrochloride, bisabolol and kojic acid for hyperpigmentation and hypertrophic scarring (Figure 6).
Keloid 104 days post-intralesional cryotherapy.
10.1177_20595131211049040-fig7.jpg
PMC8721406_01_10.1177_20595131211049040-fig7.jpg
fig7-20595131211049040
After 104 days post-procedure, the patient had mild keloid reformation and started injections of 40 mg IL triamcinolone acetonide and 5-10 units of onabotulinumtoxinA (Figure 7).
Keloid 223 days post-intralesional cryotherapy as well as three sessions of intralesional triamcinolone acetonide and onabotulinumtoxinA injections.
10.1177_20595131211049040-fig8.jpg
PMC8721406_01_10.1177_20595131211049040-fig8.jpg
fig8-20595131211049040
After 223 days post-procedure, the concentration of triamcinolone acetonide was decreased to 10 mg due to the reduction in size of the keloid (Figure 8).